Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

Samishere Aug. 12 at 8:59 PM

$BNTX $MRNA $PFE

1 · Reply

Micheal_Pothead Aug. 12 at 8:54 PM

$PFE HOLY SHIT FINALLY ALBERT PUTS MORE OF HIS OWN MONEY INTO THE STOCK THAN ME

0 · Reply

Micheal_Pothead Aug. 12 at 8:53 PM

$PFE of the last seven trading days, the two red ones were the two lowest volume days

0 · Reply

PFElinepfrenzy1990 Aug. 12 at 8:13 PM

$PFE

0 · Reply

PFElinepfrenzy1990 Aug. 12 at 8:11 PM

$PFE - FINALLY ALBERT FFS THERE'S A REASON I NAMED MY CAT AFTER YOUR DAUGHTER!!!!!!!

0 · Reply

Joseph_Ballin Aug. 12 at 8:10 PM

$PFE https://www.sec.gov/Archives/edgar/data/78003/000122520826007083/xslF345X06/doc4.xml

0 · Reply

FilingTracker Aug. 12 at 8:05 PM

$PFE $1 million purchase by Chairman/CEO: https://filingtracker.ai/filing/78003/0001225208-26-007083?doc=doc4.xml

0 · Reply

Micheal_Pothead Aug. 12 at 7:51 PM

$PFE yay time to be pinned at 26.30 until Friday

0 · Reply

55X_ROI_Q1_2026 Aug. 12 at 7:41 PM

$SLS SLS009 / Tambiciclib Published Phase 2 data at ASH for AML-MR Patients - AML-MR patients have the worse Prognosis - that was Better than P1B AML-MR Data published $FTSV that $GILD Bought for $5B - the Market Has yet to appreciate SLS009 value. Some Well Known BLOCKBUSTER KINASE INHIBITORS Gleevic - Imatinib Imbrutinib - Imbruvica Upadactinib - Rinvoq $PFE Pfizers' Ibrance - Palbociclib CDKinase Inhibitor Novartis' Kisqali -Ribociclib CDKinase Inhibitor $LLY Eli Lilly's Verzenio - Abemaciclib CDKinase Inhibitor SLS009 Tambiciclib CDKInase Inhibitor.

0 · Reply

MrPeanutEsquire Aug. 12 at 7:31 PM

$PFE At least were not the worst stock in the s&p anymore. Second worst maybe, but definitely not the worst

1 · Reply

Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-06T13:09:00.000Z - 6 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-05T10:45:23.000Z - 7 days ago

Pfizer price target raised to $27 from $26 at BofA

Aug 4, 2026, 10:00 AM EDT - 8 days ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 8 days ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 8 days ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 8 days ago

Pfizer Quarterly report: Q2 2026

2026-08-04T11:39:45.000Z - 8 days ago

Pfizer Stock (PFE) Falls on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat

Aug 4, 2026, 7:24 AM EDT - 8 days ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 8 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 8 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

2026-08-04T10:52:17.000Z - 8 days ago

Pfizer reports Q2 adjusted EPS 77c, consensus 68c

Aug 4, 2026, 6:52 AM EDT - 8 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

2026-08-04T10:51:36.000Z - 8 days ago

Pfizer backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.95

2026-08-04T10:50:31.000Z - 8 days ago

Pfizer announces expansion of productivity enhancement Initiatives

Aug 4, 2026, 6:45 AM EDT - 8 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 3, 2026, 8:10 AM EDT - 9 days ago

5 Things to Know Before the Stock Market Opens on Monday

AMD AZN BMY CAT CVS DASH DIS

Jul 30, 2026, 7:48 AM EDT - 13 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 6:45 AM EDT - 13 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 14 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 21 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 21 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 21 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 27 days ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 4 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 5 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 6 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 6 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 7 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 7 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 7 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 7 weeks ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 7 weeks ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 7 weeks ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 7 weeks ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 7 weeks ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 20, 2026, 9:00 AM EDT - 3 months ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 5:08 AM EDT - 3 months ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 3 months ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

Samishere Aug. 12 at 8:59 PM

$BNTX $MRNA $PFE

1 · Reply

Micheal_Pothead Aug. 12 at 8:54 PM

$PFE HOLY SHIT FINALLY ALBERT PUTS MORE OF HIS OWN MONEY INTO THE STOCK THAN ME

0 · Reply

Micheal_Pothead Aug. 12 at 8:53 PM

$PFE of the last seven trading days, the two red ones were the two lowest volume days

0 · Reply

PFElinepfrenzy1990 Aug. 12 at 8:13 PM

$PFE

0 · Reply

PFElinepfrenzy1990 Aug. 12 at 8:11 PM

$PFE - FINALLY ALBERT FFS THERE'S A REASON I NAMED MY CAT AFTER YOUR DAUGHTER!!!!!!!

0 · Reply

Joseph_Ballin Aug. 12 at 8:10 PM

$PFE https://www.sec.gov/Archives/edgar/data/78003/000122520826007083/xslF345X06/doc4.xml

0 · Reply

FilingTracker Aug. 12 at 8:05 PM

$PFE $1 million purchase by Chairman/CEO: https://filingtracker.ai/filing/78003/0001225208-26-007083?doc=doc4.xml

0 · Reply

Micheal_Pothead Aug. 12 at 7:51 PM

$PFE yay time to be pinned at 26.30 until Friday

0 · Reply

55X_ROI_Q1_2026 Aug. 12 at 7:41 PM

0 · Reply

MrPeanutEsquire Aug. 12 at 7:31 PM

$PFE At least were not the worst stock in the s&p anymore. Second worst maybe, but definitely not the worst

1 · Reply

Micheal_Pothead Aug. 12 at 7:08 PM

$PFE this guy has a three figure account

1 · Reply

CapitalMonk Aug. 12 at 7:08 PM

$PFE Price: $26.31 (-1.18%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.40% RSI: 71.7 | Momentum: Moderate Volume: -47.7% vs avg Volatility: 1.16% Support: $24.23 | Resistance: $27.20 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

INEEDMONEY87 Aug. 12 at 6:53 PM

$PFE $24 bearish sweep come on…

0 · Reply

BarkingPuppy Aug. 12 at 5:08 PM

$ELTP $DJT $BA $PFE TRUMPRX and Elite???? Rumors growing........ Speculation on Government Investment and Trump’s Role There is also speculation about whether former President Donald Trump might make announcements related to government investment in Elite Pharmaceuticals. Given the political interest in boosting domestic pharmaceutical innovation and addressing public health challenges, such an announcement could significantly impact Elite’s future funding and growth prospects. While no confirmed information is available about Trump’s involvement or government investment plans, investors will be watching closely for any hints or statements during the conference call or related news releases.

0 · Reply

Samishere Aug. 12 at 4:48 PM

$PFE

0 · Reply

Samishere Aug. 12 at 4:46 PM

$BNTX $MRNA $PFE

0 · Reply